What you need to know for Wednesday’s hearing 

The House Energy and Commerce health subcommittee will hold a hearing Wednesday on “making prescriptions more affordable.” The hearing is mostly about Pelosi’s drug pricing bill, but that proposal — dubbed H.R. 3  or the "Lower Drug Costs Now Act of 2019" — isn’t the only one set to be considered. Here’s what you need to know about the others:

One bill from Rep. Peter Welch (D-Vt.) would repeal the portion of existing law banning the HHS secretary from negotiating the price of drugs. The bill comes in at just three pages.

Another, from Rep. Elijah Cummings (D-Md.), would also direct the HHS secretary to negotiate the price of drugs and when negotiations fall through would direct HHS to base the price it will pay on the lowest of the average paid by five countries, the Medicaid “best price,” or the price paid by the Department of Veterans Affairs.

Like the rest of the proposals, a third bill from Rep. Lloyd Doggett (D-Texas) would let HHS negotiate the price of drugs and would allow generics to launch early when those negotiations fall through.

Set to testify at Wednesday’s hearing are Baldwin Wallace University’s Robert Fowler, Johns Hopkins’ Gerard Anderson, and AEI’s Benedic Ippolito.